Fetal Liver Bisphenol A Concentrations and Biotransformation Gene Expression Reveal Variable Exposure and Altered Capacity for Metabolism in Humans

Journal of Biochemical and Molecular Toxicology

Volumn 27, Issue 2, 2013, Pages 116-123

  Nahar, Muna S ^a   Liao, Chunyang ^b   Kannan, Kurunthachalam ^b   Dolinoy, Dana C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Biomonitoring; Biotransformation; Bisphenol A; Liver

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BETA GLUCURONIDASE; GLUCURONOSYLTRANSFERASE; MESSENGER RNA; STERYL SULFATASE; SULFOTRANSFERASE;

ARTICLE; BIOLOGICAL MONITORING; BIOTRANSFORMATION; CONTROLLED STUDY; FETUS; FETUS LIVER; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LIMIT OF QUANTITATION; LIVER METABOLISM; NUCLEOTIDE SEQUENCE; PREGNANCY; PREGNANCY TERMINATION; PRENATAL EXPOSURE; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY;

ADULT; BENZHYDRYL COMPOUNDS; BIOTRANSFORMATION; ESTROGENS, NON-STEROIDAL; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIVER; MALE; MIDDLE AGED; PHENOLS; PREGNANCY;

EID: 84874022332     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21459     Document Type: Article

References (45)

1. Ben-Jonathan N, Steinmetz R. Xenoestrogens: the emerging story of bisphenol A. Trends Endocrinol Metab 1998;9(3):124-128.
2. Fleisch AF, Sheffield PE, Chinn C, Edelstein BL, Landrigan PJ. Bisphenol A and related compounds in dental materials. Pediatrics 2010;126(4):760-768.
3. Kubwabo C, Kosarac I, Stewart B, Gauthier BR, Lalonde K, Lalonde PJ. Migration of bisphenol A from plastic baby bottles, baby bottle liners and reusable polycarbonate drinking bottles. Food Addit Contam, Part A: Chem Anal Control Expo Risk Assess 2009;26(6):928-937.
4. Goodson A, Summerfield W, Cooper I. Survey of bisphenol A and bisphenol F in canned foods. Food Addit Contam 2002;19(8):796-802.
5. Liao C, Kannan K. Widespread occurrence of bisphenol A in paper and paper products: implications for human exposure. Environ Sci Technol 2011;45(21):9372-9379.
6. Calafat A, Ye X, Wong L, Reidy J, Needham L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008;116(1):39-44.
7. Zhang Z, Alomirah H, Cho HS, Li YF, Liao C, Minh TB, Mohd MA, Nakata H, Ren N, Kannan K. Urinary bisphenol A concentrations and their implications for human exposure in several Asian countries. Environ Sci Technol 2011;45(16):7044-7050.
8. Maffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol 2006;254-255:179-186.
9. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Jr., Lee DH, Shioda T, Soto AM, Vom Saal FS, Welshons WV and others. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012;33(3):378-455.
10. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008;300(11):1303-1310.
11. Meeker JD, Ehrlich S, Toth TL, Wright DL, Calafat AM, Trisini AT, Ye X, Hauser R. Semen quality and sperm DNA damage in relation to urinary bisphenol A among men from an infertility clinic. Reprod Toxicol 2010;30(4):532-539.
12. Sugiura-Ogasawara M, Ozaki Y, Sonta S, Makino T, Suzumori K. Exposure to bisphenol A is associated with recurrent miscarriage. Hum Reprod 2005;20(8):2325-2329.
13. Braun JM, Kalkbrenner AE, Calafat AM, Yolton K, Ye X, Dietrich KN, Lanphear BP. Impact of early-life bisphenol a exposure on behavior and executive function in children. Pediatrics 2011;128(5):873-882.
14. Gould JC, Leonard LS, Maness SC, Wagner BL, Conner K, Zacharewski T, Safe S, McDonnell DP, Gaido KW. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol 1998;142(1-2):203-214.
15. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139(10):4252-4263.
16. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Shimatsu A, Kuzuya H, Nakao K. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 2002;87(11):5185-5190.
17. Thomas P, Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol 2006;102(1-5):175-179.
18. Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol Lett 2006;167(2):95-105.
19. Sui Y, Ai N, Park SH, Rios-Pilier J, Perkins JT, Welsh WJ, Zhou C. Bisphenol A and its analogues activate human pregnane X receptor. Environ Health Perspect 2012;120(3):399-405.
20. Kruger T, Long M, Bonefeld-Jorgensen EC. Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology 2008;246(2-3):112-123.
21. Hanioka N, Naito T, Narimatsu S. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 2008;74(1):33-36.
22. Nishiyama T, Ogura K, Nakano H, Kaku T, Takahashi E, Ohkubo Y, Sekine K, Hiratsuka A, Kadota S, Watabe T. Sulfation of environmental estrogens by cytosolic human sulfotransferases. Drug Metab Pharmacokinet 2002;17(3):221-228.
23. Hines RN, McCarver DG. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 2002;300(2):355-360.
24. McCarver DG, Hines RN. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 2002;300(2):361-366.
25. Sperker B, Backman JT, Kroemer HK. The role of beta-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 1997;33(1):18-31.
26. Kriz L, Bicikova M, Hampl R. Roles of steroid sulfatase in brain and other tissues. Physiol Res 2008;57(5):657-668.
27. Jimenez-Diaz I, Zafra-Gomez A, Ballesteros O, Navea N, Navalon A, Fernandez MF, Olea N, Vilchez JL. Determination of Bisphenol A and its chlorinated derivatives in placental tissue samples by liquid chromatography-tandem mass spectrometry. J Chromatogr B: Analyt Technol Biomed Life Sci 2010;878(32):3363-3369.
28. Cao XL, Zhang J, Goodyer CG, Hayward S, Cooke GM, Curran IH. Bisphenol A in human placental and fetal liver tissues collected from Greater Montreal area (Quebec) during 1998-2008. Chemosphere 2012;89(5):505-511.
29. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002;17(11):2839-2841.
30. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005;113(4):391-395.
31. Tungwiwat W, Fucharoen G, Ratanasiri T, Sanchaisuriya K, Fucharoen S. Non-invasive fetal sex determination using a conventional nested PCR analysis of fetal DNA in maternal plasma. Clin Chim Acta 2003;334(1-2):173-177.
32. Anderson OS, Nahar MS, Faulk C, Jones TR, Liao C, Kannan K, Weinhouse C, Rozek LS, Dolinoy DC. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen 2012;53(3):334-342.
33. Padmanabhan V, Siefert K, Ransom S, Johnson T, Pinkerton J, Anderson L, Tao L, Kannan K. Maternal bisphenol-A levels at delivery: a looming problem? J Perinatol 2008;28(4):258-263.
34. Yamada H, Furuta I, Kato EH, Kataoka S, Usuki Y, Kobashi G, Sata F, Kishi R, Fujimoto S. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol 2002;16(6):735-739.
35. Koch HM, Kolossa-Gehring M, Schroter-Kermani C, Angerer J, Bruning T. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: A retrospective exposure evaluation. J Expo Sci Environ Epidemiol 2012;22(6):610-616.
36. Liao C, Kannan K. Determination of free and conjugated forms of bisphenol a in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ Sci Technol 2012;46(9):5003-5009.
37. Edlow AG, Chen M, Smith NA, Lu C, McElrath TF. Fetal bisphenol A exposure: concentration of conjugated and unconjugated bisphenol A in amniotic fluid in the second and third trimesters. Reprod Toxicol 2012;34(1):1-7.
38. Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 2002;50(2):259-265.
39. Miki Y, Nakata T, Suzuki T, Darnel AD, Moriya T, Kaneko C, Hidaka K, Shiotsu Y, Kusaka H, Sasano H. Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J Clin Endocrinol Metab 2002;87(12):5760-5768.
40. Lucier GW, Sonawane BR, McDaniel OS. Glucuronidation and deglucuronidation reactions in hepatic and extrahepatic tissues during perinatal development. Drug Metab Dispos 1977;5(3):279-287.
41. Collier AC, Tingle MD, Paxton JW, Mitchell MD, Keelan JA. Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. Hum Reprod 2002;17(10):2564-2572.
42. Stanley EL, Hume R, Coughtrie MW. Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol Cell Endocrinol 2005;240(1-2):32-42.
43. Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge-Morris M. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 2006;316(3):1310-1317.
44. Hanioka N, Oka H, Nagaoka K, Ikushiro S, Narimatsu S. Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation. Arch Toxicol 2011;85(11):1373-1381.
45. Abduljalil K, Furness P, Johnson TN, Rostami-Hodjegan A, Soltani H. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling. Clin Pharmacokinet 2012;51(6):365-396.